Stryker (SYK) Form 144: Sale of 2,026 shares, $740,482 value

Stryker Corporation (SYK): Form 144 notice of proposed sale.

Rhea-AI Filing Summary

Stryker Corporation (SYK): Form 144 notice of proposed sale. A security holder filed to sell up to 2,026 shares of SYK common stock. The filing lists an aggregate market value of $740,482, an approximate sale date of 11/14/2025, and execution on the NYSE through UBS Financial Services Inc.

The shares were acquired on 11/14/2025 via an options exercise, with payment by wire on the same date. Shares outstanding were 382,164,865; this is a baseline figure, not the amount being sold.

Insights

Securities law analyst

Routine Form 144 for a small planned sale; neutral impact.

Stryker is the issuer in a Form 144 notice covering up to 2,026 shares of common stock with an $740,482 aggregate market value. The filing identifies UBS Financial Services Inc. as broker, with trades on the NYSE and an approximate sale date of 11/14/2025.

The seller acquired these shares via options exercise on 11/14/2025, paid by wire the same day. Relative to 382,164,865 shares outstanding, the notice is small in scale. Actual sales, if any, depend on the holder’s decisions and market conditions as permitted under Rule 144.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Stryker (SYK)’s Form 144 disclose?

A security holder filed a notice to sell up to 2,026 SYK common shares with an aggregate market value of $740,482.

When might the SYK shares be sold under this Form 144?

The filing lists an approximate sale date of 11/14/2025.

How were the SYK shares obtained before the planned sale?

They were acquired via an options exercise on 11/14/2025, with payment by wire.

Which broker and exchange are listed for the SYK sale?

The broker is UBS Financial Services Inc., and the exchange is the NYSE.

How many Stryker shares are outstanding for context?

382,164,865 shares were outstanding; this is a baseline figure, not the amount being sold.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/14/2025 - 04:27 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001600806
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Stryker Corporation
SEC File Number	001-13149
Address of Issuer	1941 Stryker Way Portage MICHIGAN 49002
Phone	2693852600
Name of Person for Whose Account the Securities are To Be Sold	William Berry Jr
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	2026	740482	382164865	11/14/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/14/2025	Options Exercise	Stryker Corporation			2026	11/14/2025	Wire

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	11/14/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact for William Berry Jr
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)